Pharma-Bio Serv, Inc. (PBSV)
0.4161
-0.05
(-10.15%)
USD |
OTCM |
Oct 07, 16:00
Pharma-Bio Serv Gross Profit Margin (Quarterly) : 29.61% for July 31, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | 29.61% |
| April 30, 2026 | 33.37% |
| January 31, 2026 | 31.48% |
| October 31, 2025 | 34.84% |
| July 31, 2025 | 29.25% |
| April 30, 2025 | 33.87% |
| January 31, 2025 | 31.08% |
| October 31, 2024 | 31.14% |
| July 31, 2024 | 26.28% |
| April 30, 2024 | 26.01% |
| January 31, 2024 | 22.50% |
| October 31, 2023 | 25.84% |
| July 31, 2023 | 33.86% |
| April 30, 2023 | 29.51% |
| January 31, 2023 | 29.26% |
| October 31, 2022 | 23.90% |
| July 31, 2022 | 27.49% |
| April 30, 2022 | 24.48% |
| January 31, 2022 | 24.80% |
| October 31, 2021 | 26.78% |
| July 31, 2021 | 25.16% |
| April 30, 2021 | 25.60% |
| January 31, 2021 | 29.30% |
| October 31, 2020 | 27.02% |
| July 31, 2020 | 29.53% |
| Date | Value |
|---|---|
| April 30, 2020 | 33.09% |
| January 31, 2020 | 34.38% |
| October 31, 2019 | 31.89% |
| July 31, 2019 | 31.53% |
| April 30, 2019 | 30.94% |
| January 31, 2019 | 32.39% |
| October 31, 2018 | 50.14% |
| July 31, 2018 | 34.41% |
| April 30, 2018 | 27.54% |
| January 31, 2018 | 31.70% |
| October 31, 2017 | 16.78% |
| July 31, 2017 | 23.32% |
| April 30, 2017 | 26.55% |
| January 31, 2017 | 25.51% |
| October 31, 2016 | 23.16% |
| July 31, 2016 | 29.30% |
| April 30, 2016 | 29.71% |
| January 31, 2016 | 35.88% |
| October 31, 2015 | 34.82% |
| July 31, 2015 | 33.10% |
| April 30, 2015 | 30.98% |
| January 31, 2015 | 28.99% |
| October 31, 2014 | 32.69% |
| July 31, 2014 | 31.86% |
| April 30, 2014 | 31.79% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Cryoport, Inc. | 39.66% |
| ICON plc | 18.83% |
| IQVIA Holdings, Inc. | 26.20% |
| Eurofins Scientific SE | -- |
| Proteome Sciences Plc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 2.29% |
| Return on Assets | 1.97% |
| Return on Invested Capital | 2.28% |
| Profit Margin (Quarterly) | -0.61% |
| Operating Margin (Quarterly) | -3.07% |
| Return on Net Operating Assets | 3.20% |